Helius Medical Technologi... (HSDT)
Helius Medical Statistics
Share Statistics
Helius Medical has 6.13M shares outstanding. The number of shares has increased by 91.49% in one year.
| Shares Outstanding | 6.13M |
| Shares Change (YoY) | 91.49% |
| Shares Change (QoQ) | 52.2% |
| Owned by Institutions (%) | 0.02% |
| Shares Floating | 6.07M |
| Failed to Deliver (FTD) Shares | 1.27K |
| FTD / Avg. Volume | 0.06% |
Short Selling Information
The latest short interest is 16.61K, so 0.45% of the outstanding shares have been sold short.
| Short Interest | 16.61K |
| Short % of Shares Out | 0.45% |
| Short % of Float | 0.45% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -1.55 and the forward PE ratio is -0.79. Helius Medical's PEG ratio is 0.02.
| PE Ratio | -1.55 |
| Forward PE | -0.79 |
| PS Ratio | 34.93 |
| Forward PS | 0 |
| PB Ratio | 17.15 |
| P/FCF Ratio | -1.64 |
| PEG Ratio | 0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Helius Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.58 |
| Quick Ratio | 1.1 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $24.76K |
| Profits Per Employee | $-559.14K |
| Employee Count | 21 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 0.56 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -94.52% in the last 52 weeks. The beta is 1.28, so Helius Medical's price volatility has been higher than the market average.
| Beta | 1.28 |
| 52-Week Price Change | -94.52% |
| 50-Day Moving Average | 0.44 |
| 200-Day Moving Average | 0.62 |
| Relative Strength Index (RSI) | 29.07 |
| Average Volume (20 Days) | 2.05M |
Income Statement
In the last 12 months, Helius Medical had revenue of 520K and earned -11.74M in profits. Earnings per share was -0.43.
| Revenue | 520K |
| Gross Profit | -62K |
| Operating Income | -13.9M |
| Net Income | -11.74M |
| EBITDA | -13.8M |
| EBIT | -13.86M |
| Earnings Per Share (EPS) | -0.43 |
Balance Sheet
The company has 1.09M in cash and 12K in debt, giving a net cash position of 1.08M.
| Cash & Cash Equivalents | 1.09M |
| Total Debt | 12K |
| Net Cash | 1.08M |
| Retained Earnings | -171.7M |
| Total Assets | 3.54M |
| Working Capital | 1.26M |
Cash Flow
In the last 12 months, operating cash flow was -11.04M and capital expenditures -5K, giving a free cash flow of -11.05M.
| Operating Cash Flow | -11.04M |
| Capital Expenditures | -5K |
| Free Cash Flow | -11.05M |
| FCF Per Share | -0.41 |
Margins
Gross margin is -11.92%, with operating and profit margins of -2673.65% and -2258.08%.
| Gross Margin | -11.92% |
| Operating Margin | -2673.65% |
| Pretax Margin | -2258.08% |
| Profit Margin | -2258.08% |
| EBITDA Margin | -2654.42% |
| EBIT Margin | -2673.65% |
| FCF Margin | -2124.23% |
Dividends & Yields
HSDT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for HSDT is $24, which is 8471.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $24 |
| Price Target Difference | 8471.4% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Aug 17, 2023. It was a backward split with a ratio of 1:50.
| Last Split Date | Aug 17, 2023 |
| Split Type | backward |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | -79.78 |
| Piotroski F-Score | 3 |